The BET Bromodomain Inhibitor ZEN-3365 Targets the Hedgehog Signaling Pathway in Acute Myeloid Leukemia

0
9
Scientists investigated the effect of ZEN-3365, a novel BRD4 inhibitor, on acute myeloid leukemia cells in regard to the Hedgehog pathway.
[Annals of Hematology]
Full Article